All Articles

Tigera, the force behind Calico, launches Lynx to rein in chaotic AI agents, offering a kernel-deep control plane for a new era of enterprise security.

Parabola's new Prowork platform aims to build trust in AI by letting ops and finance teams automate complex tasks using plain English, with no black box.

Over 9,000 pounds of batteries were just recycled by students in Vermont. This isn't just a cleanup—it's a lesson in securing a future less dependent on foreign supply chains.

As Pinky Cole Hayes brings her vegan brand to Detroit, it's more than an expansion. It's a test of a new business model built on celebrity and resilience.

Sugar House Distillery is expanding its canned cocktails into Idaho, a strategic move testing if its 'grain-to-glass' ethos can capture a new market.

Colorado agency Bluebird Branding launches The Nest, a platform aiming to unify brand assets and messaging. Is this the future for creative services?

As lawsuits plague synthetic weed killers, Akron-based Lanaturo unveils Salacia, the first selective organic herbicide guided by AI, shaking up the lawn care industry.

Thirty years ago, a US human rights report on a mining giant disappeared. A new investigation asks why, exposing a pattern of secrecy and human cost.

A unique 'double feature' in Rocky Mount pairs local artists with a prison art program, revealing art's power for community building and rehabilitation.

As employees flock to prediction markets, a new insider trading risk emerges. A new tech alliance aims to give firms the visibility they've been missing.

Painterland Sisters just declared National Skyr Yogurt Day. It's not just a PR stunt; it's a masterclass in modern brand-building and a bet on the future of dairy.

As giants rule the obesity market, small-cap MetaVia pitches a novel dual-agonist and a first-in-class MASH drug. Can its science win the day?

As ad tech firm Swivel staffs up with industry veterans, it's not just building a company—it's signaling the ad industry's shift from AI hype to execution.

As Terry Duffy moves to Executive Chairman, Lynne Fitzpatrick prepares to lead CME. This isn't just succession; it's a calculated move for a new digital era.

A new mid-year outlook reveals how geopolitical turmoil, the AI boom, and a renewed focus on sovereignty are reshaping investment strategies for a volatile H2 2026.

XCharge's new C7 charger boasts record power, but its real test lies in winning public trust. A deep dive into the tech, strategy, and partnerships redefining speed.

Verastem Oncology's combo therapy posts impressive early data in a notoriously deadly cancer, revealing a shrewd strategy for tackling drug resistance.

Glass House Brands follows a new playbook, splitting its business to chase a NYSE listing. Is this the key that unlocks institutional capital for the entire sector?

A landmark grant and trial expansion signal a pivotal shift in Parkinson's research, blending genetic targeting, global collaboration, and digital health.

With a promising drug and a fortified war chest, Trevi Therapeutics’ upcoming conference tour is a calculated move to conquer a vast, unmet medical need.